Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-15

Clinical Trial Update: Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial results compare THDB0206 with insulin lispro injection in participants with Type 1 diabetes, evaluating efficacy and safety. The study status is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin lispro injection (insulin lispro)
  • THDB0206 (THDB0206)

Snippet

Sponsor: Tonghua Dongbao Pharmaceutical Co.,Ltd | Conditions: Type 1 Diabetes | Phase 3 | Status: COMPLETED